Upload FCS files to the hema.to platform just by dropping them in the cloud. Results will be generated within seconds.
Noise out, signal in
Debri obscuring the signal are filtered out.Single cell classification highlights populations of interest.Tiniest populations are identified.
Control AI, control insights
Disagree with the generated results?Manually adjust the populations.All cytograms will reflect the change
No more manual reports
A report with your results will automatically be generated based on the template that you provide us.
01
02
03
04
Multiple solutions under the Galen™ platform are CE marked (IVDD) and registered with the UK MHRA and ANVISA in Brazil. Galen First Read for prostate is also CE marked under IVDR. The Galen platform includes solutions which are for Research Use Only (RUO) in the United States and not cleared by the FDA. Contact us for more information, including indication for use and regulatory approval in other countries.
